Largest Autism Inpatient Cohort Releases Genetic and Phenotypic Data for Over 1,500 Children

SFARI has released a groundbreaking dataset of genetic and phenotypic data from over 1,500 hospitalized children with autism, focusing on those with profound autism. This resource aims to accelerate research and targeted interventions for individuals with high support needs.
The Simons Foundation Autism Research Initiative (SFARI) has unveiled a comprehensive dataset comprising genetic and phenotypic information from the Autism Inpatient Collection (AIC). This cohort includes more than 1,500 children and adolescents aged 4 to 20 years, all of whom were hospitalized across six child psychiatry units in the United States. The AIC was established to focus on individuals with severe forms of autism, often characterized by intellectual disabilities or minimal verbal communication, necessitating high levels of supervision and support. These individuals are notably underrepresented in outpatient and community-based datasets.
According to Matthew Siegel of Boston Children's Hospital, who founded and leads the AIC, "This dataset is the largest single collection of information on hospitalized children with autism, many of whom meet the criteria for profound autism." The goal is to use this rich dataset, which pairs detailed behavioral and cognitive phenotypic measures with high-confidence genetic data, to accelerate research into autism, especially in children with the most urgent needs.
The data encompass key domains such as behavior, communication, emotional regulation, adaptive functioning, cognition, sleep, and parent stress and self-efficacy—offering an in-depth view of this challenging segment of the autism spectrum. Phenotypic assessments are detailed and can be reviewed in the Researcher Welcome Packet.
Biological samples, including blood or saliva when blood wasn't feasible, were collected from the children and their biological parents. These samples are stored in a centralized repository managed by SFARI. Whole-exome sequencing data derived from these samples are now accessible to researchers.
Kelsey Martin, executive vice president of autism and neuroscience at the Simons Foundation, expressed enthusiasm about the resource, highlighting its potential to improve understanding and treatment for people with high support needs. She acknowledged the contributions of participants and researchers over the past decade and emphasized that the dataset is expected to foster new discoveries in autism research.
All data and biospecimens are available for authorized use through SFARI Base, facilitating ongoing scientific advancement in understanding autism, especially in individuals with profound support requirements.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding the Causes of Autism Spectrum Disorder
Explore the latest insights into the genetic and environmental factors contributing to autism spectrum disorder, and what current research reveals about its causes.
Early Advances in mRNA-Based HIV Vaccine Strategies from Dual Studies
Recent dual studies highlight promising early results in HIV vaccine development using mRNA technology, focusing on inducing potent neutralizing antibodies and durable immune responses.
The Enigma of Tickling: Unraveling a 2,000-Year-Old Mystery
Explore the fascinating science behind tickling, its neural mechanisms, evolutionary purpose, and its significance in social bonding and neurological research, a mystery still unsolved after 2,000 years.
Enhancing Gene Research Accuracy with Bayesian Learning Techniques
Discover how Bayesian hierarchical modeling is revolutionizing gene research by enabling more accurate identification of transcriptional regulators, with significant implications for disease understanding and treatment development.



